New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AET;RHHBY;MCD;DST;SYT;AKR;ATHN;TSM;MPEL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 20, 2014
06:38 EDTATHNathenahealth price target lowered to $115 from $140 at RBC Capital
Subscribe for More Information
October 19, 2014
18:11 EDTMCDRussia temporarily suspends nine McDonald's restaurants in the country
Subscribe for More Information
16:28 EDTSYTSyngenta faces more lawsuits over genetically engineered corn seeds, WSJ says
Subscribe for More Information
October 17, 2014
10:00 EDTTSMOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AK Steel (AKS) upgraded to Buy from Neutral at Nomura... AMD (AMD) upgraded to Sector Perform from Underperform at Pacific Crest... Atlantic Power (AT) upgraded to Market Perform from Underperform at BMO Capital... Basic Energy (BAS) upgraded to Outperform from Market Perform at Cowen... BorgWarner (BWA) upgraded to Buy from Hold at Deutsche Bank... CA Technologies (CA) upgraded to Overweight from Equal Weight at Barclays... Calumet Specialty Products (CLMT) upgraded to Outperform at Wells Fargo... DHT Holdings (DHT) upgraded to Buy from Hold at Evercore... Exelon (EXC) upgraded to Neutral from Sell at Citigroup... Fifth Third Bancorp (FITB) upgraded to Buy from Neutral at Citigroup... Goldman Sachs (GS) upgraded to Outperform from Market Perform at Keefe Bruyette... Helmerich & Payne (HP) upgraded to Buy from Neutral at UBS... Hilton (HLT) upgraded to Buy from Neutral at SunTrust... Hyatt Hotels (H) upgraded to Outperform from Neutral at Macquarie... IPG Photonics (IPGP) upgraded at Stifel... ITC Holdings (ITC) upgraded to Neutral from Underperform at Credit Suisse... Manpower (MAN) upgraded to Outperform from Market Perform at Avondale... Nabors Industries (NBR) upgraded to Outperform from Market Perform at Cowen... Newpark Resources (NR) upgraded at Cowen... Old Dominion (ODFL) upgraded to Buy from Neutral at Longbow... PDC Energy (PDCE) upgraded at SunTrust... Patterson-UTI (PTEN) upgraded to Buy from Neutral at UBS... PrivateBancorp (PVTB) upgraded to Outperform from Neutral at Macquarie... QLogic (QLGC) upgraded to Buy from Hold at Summit Research... RPC, Inc. (RES) upgraded at Cowen... Sonoco (SON) upgraded to Neutral from Underperform at DA Davidson... Southwestern Energy (SWN) upgraded to Outperform from Market Perform at Raymond James... SunEdison (SUNE) upgraded to Outperform at Cowen... TSMC (TSM) upgraded to Buy from Neutral at Mizuho... Tesco (TESO) upgraded to Outperform from Market Perform at Cowen... UnitedHealth (UNH) upgraded to Outperform from Market Perform at Leerink... Xilinx (XLNX) upgraded to Outperform from Market Perform at Wells Fargo.
09:17 EDTATHNOn The Fly: Pre-market Movers
Subscribe for More Information
08:05 EDTATHNathenahealth reports Q3 adjusted EPS 27c, consensus 27c
athenahealth last night reported Q3 revenue $190.4M, consensus $190.4M. The company reported it grew net new active physicians on athenaCollector, which had 3,420 physicians added, athenaClinicals, which had 2,786 physicians added, and athenaCommunicator, which had 3,846 physicians added, for the three months ended September 30.
07:59 EDTTSMTSMC upgraded to Buy from Neutral at Mizuho
Subscribe for More Information
06:26 EDTTSMTSMC to start production of 16nm process products in 2Q15, DigiTimes says
Subscribe for More Information
October 16, 2014
18:36 EDTATHNOn The Fly: After Hours Movers
Subscribe for More Information
16:07 EDTATHNathenahealth now sees FY14 EPS near high end of range
athenahealth said, "We are not making any changes to the fiscal year 2014 guidance...However, based on our year-to-date performance and current expectations for Q4 2014, we are providing additional insight into our fiscal year 2014 guidance as follows: "We expect GAAP Total Revenue to be at or above the mid-point of the $725M-$755M guidance range. We expect Non-GAAP Adjusted Gross Margin to be close to the mid-point of the 62.5% to 63.5% guidance range. We expect Non-GAAP Adjusted Net Income per Diluted share to be close to the high end of the 98c-$1.10 guidance range."
16:05 EDTATHNathenahealth sees FY14 adjusted EPS 98c-$1.10, consensus $1.09
Subscribe for More Information
14:47 EDTRHHBYRoche in pact with Pharmacyclics to evaluate Imbruvica, Gazyva combo
Subscribe for More Information
14:13 EDTSYTU.S farmers use less fertilizer this autumn as crop prices fade, Reuters says
Subscribe for More Information
13:13 EDTRHHBYRoche considers submitting Ebola test for emergency use approval, WSJ says
Subscribe for More Information
12:54 EDTTSMTSMC upgraded to Overweight from Neutral at HSBC
Subscribe for More Information
11:15 EDTTSMHigh option volume stocks
Subscribe for More Information
09:35 EDTRHHBYDiplomat announces contract to distribute Esbriet
Subscribe for More Information
06:21 EDTMCDMcDonald's rehires former U.S. executive, WSJ reports
Subscribe for More Information
05:58 EDTRHHBYRoche sees FY14 core EPS targeted to grow ahead of sales
Subscribe for More Information
05:56 EDTRHHBYRoche reports 9 month revenue CHF34.76B vs. CHF34.87B last year
Roche CEO Severin Schwan said: “Demand for our products is strong in both divisions and we are well on track to reach our full-year targets. We have had positive news from our product pipeline, including study results for Perjeta in breast cancer and a new combination therapy with Zelboraf in melanoma. The InterMune acquisition has also strengthened our portfolio with a new medicine, Esbriet for idiopathic pulmonary fibrosis, which has now been approved by the FDA. In Diagnostics, growth continues to be driven by the immunodiagnostics business and we have strengthened our molecular diagnostics portfolio with a new generation of testing systems.”
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use